Delivery Order SPE2DB25D2204-SPE2DB25FTFYU

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,272.96, is a Firm Fixed Price Delivery Order for the supply of Allegra Allergy 180 mg tablets. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,453.83 firm fixed-price delivery order is for the supply of Allegra Allergy 180 mg tablets and has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,132.95 Firm Fixed Price Delivery Order contract is for the supply of Allegra Allergy 180 mg tablets. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,060.80 firm fixed-price delivery order covers the supply of Allegra Allergy 180 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,137.45 firm fixed-price delivery order is for the supply of Allegra Allergy 180 mg tablets. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. There was no set-aside designation for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,182.40, is for the delivery of Allegra Allergy 180 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 3, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,684.70, is for the delivery of Allegra Allergy 180 mg tablets. It is a firm fixed-price delivery order contract that runs through January 15, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Allegra Allergy 180 mg tablets, a pharmaceutical product, with a ceiling value of $1,007.76 and a performance period ending on January 7, 2025. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Allegra Allergy 180 mg tablets, a pharmaceutical product, with a ceiling value of $1,648.08 and a period of performance through February 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $31,736.82, is for the delivery of ALLEGRA ALLERGY 180 MG TABLET 30S. This is a firm fixed price delivery order contract with a period of performance through September 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen has been awarded numerous federal contracts by the DLA and other...
  • SPE2DB25D2204
    Indefinite Delivery Contract
  • SPE2DB25D2204-SPE2DB25FTFYU
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,903.00 for the supply of Allegra Allergy 180 mg tablets to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price agreement.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is likely part of that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 4/24/25, 9:42 AM